|
Results for Clostridium tetani
|
On this page:
|
(medicine) A spore-forming bacterium that produces a powerful toxin, tetanospasmin, that blocks inhibitory synapses in the central nervous system and thus causes the severe muscle spasms characteristic of tetanus.
| Clostridium tetani | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Clostridium tetani with characteristic 'tennis racket' appearance.
|
||||||||||||||
| Scientific classification | ||||||||||||||
|
||||||||||||||
| Binomial name | ||||||||||||||
| Clostridium tetani Flügge, 1886 |
Clostridium tetani is a rod-shaped, anaerobic bacterium of the genus Clostridium. Like other Clostridium species, it is Gram-positive, and its appearance on a gram stain resembles tennis rackets or drumsticks.[1] C. tetani is found as spores in soil or as parasites in the gastrointestinal tract of animals. C. tetani produces a potent biological toxin, tetanospasmin, and is the causative agent of tetanus.
Tetanus was well known to ancient peoples, who recognized the relationship between wounds and
fatal muscle spasms. In 1884, Arthur Nicolaier isolated the strychnine-like toxin of tetanus
from free-living, anaerobic soil bacteria. The etiology of the disease was further elucidated in 1884 Antonio Carle and Giorgio
Rattone, who demonstrated the transmissibility of tetanus for the first time. They produced tetanus in rabbits by injecting their
sciatic nerve with pus from a fatal human tetanus case in that same year. In 1889, C. tetani was isolated from a human
victim, by Kitasato Shibasaburo, who later showed that the organism could produce
disease when injected into animals, and that the toxin could be neutralized by specific
C. tetani is a rod-shaped, obligate anaerobe which stains Gram positive in fresh cultures; established cultures may stain Gram negative.[1] During vegetative growth, the organism cannot survive in the presence of oxygen, is sensitive to heat and has flagella which provide limited mobility. As the bacterium matures, it develops a terminal spore, which gives the organism its characteristic appearance. C. tetani spores are extremely hardy, and are resistant to heat and most antiseptics.[3] The spores are distributed widely in manure-treated soils, and can also be found on human skin and in contaminated heroin.[2]
C. tetani usually enters a host through a wound to the skin, it then replicates and germinates spores. Once an infection is established, C. tetani produces two exotoxins, tetanolysin and tetanospasmin. Eleven strains of C. tetani have been identified, which differ primarily in flagellar antigens and in its ability to produce tetanospasmin. The genes that produce toxin are encoded on a plasmid which is present in all toxigenic strains, and all strains that are capable of producing toxin produce identical toxins.[4]
Tetanolysin serves no known function to C. tetani, and the reason the bacteria produce it is not known with certainty. Tetanospasmin is a neurotoxin and causes the clinical manifestations of tetanus. Tetanus toxin is generated in living bacteria, and is released when the bacteria lyses, such as during spore germination or during vegetative growth. A minimal amount of spore germination and vegetative cell growth are required for toxin production.[4]
On the basis of weight, tetanospasmin is one of the most potent toxins known. The estimated minimum human lethal dose is 2.5 nanograms per kilogram of body weight, or 175 nanograms in a 70 kg (154 lb) human.[2] The only toxins more lethal to humans are botulinum toxin, produced by Clostridium botulinum and the exotoxin produced by Corynebacterium diphtheriae, the causative agent of diphtheria.
Tetanospasmin is a zinc-dependent metalloproteinase, that is similar in structure to botulinum toxin, but each toxin produces quite different effects. C. tetani synthesizes tetanospasmin as a single 150kDa polypeptide progenitor toxin, that is then cleaved by a protease into two fragments; fragment A (a 50kDa "light chain") and fragment B (a 100 kDa heavy chain) which remain connected via a disulfide bridge. Cleavage of the progenitor toxin into A and B fragments can also be induced artificially with trypsin.[4]
Tetanospasmin is distributed in the blood and lymphatic system of the host. The toxin acts at several sites within the central nervous system, including peripheral nerve terminals, the spinal cord, and brain, and within the sympathetic nervous system. The toxin is taken up into within the nerve axon and transported across synaptic junctions, until it reaches the central nervous system, where it is rapidly fixed to gangliosides at the presynaptic junctions of inhibitory motor nerve endings.[2]
The clinical manifestations of tetanus are caused when tetanus toxin blocks inhibitory impulses, by interfering with the release of neurotransmitters, including glycine and gamma-aminobutyric acid. This leads to unopposed muscle contraction and spasm. Seizures may occur, and the autonomic nervous system may also be affected. Tetanospasmin appears to prevent the release of neurotransmitters by selectively cleaving a component of synaptic vesicles called synaptobrevin II.[4]
When a tetanus infection becomes established, treatment usually focuses on controlling muscle spasms, stopping toxin production, and neutralizing the effects of the toxin. Treatment includes administration of tetanus immune globulin (TIG), which comprises antibodies that inhibit tetanus toxin (also known as tetanus antitoxins), by binding to and removing unbound tetanus toxin from the body. Binding of the toxin to the nerve endings appears to be an irreversible event, and TIG is ineffective at removing bound toxin. Recovery of affected nerves requires the sprouting of a new axon terminal.[4] Large doses of antibiotic drugs (such as metronidazole or intramuscular penicillin G) are also given once tetanus infection is suspected, to halt toxin production.
Prevention of tetanus includes vaccination, and cleaning the primary wound. Prophylaxis is effective, in the form of a tetanus toxoid vaccine, which is given with or without passive immunization with tetanus immune globulin. Very few cases of tetanus have occurred in individuals with up-to-date tetanus vaccinations. DTP vaccine (diphtheria-pertussis-tetanus) in North America, is given at 2, 4, 6, and 15–18 months of age, followed by a booster before entry to school (4-6 years). This regimen provides protection from tetanus for about 10 years, and every 10 years, thereafter a booster shot of tetanus vaccine is recommended.[2]
Tetanus is not contagious from person to person, and is the only vaccine-preventable disease that is infectious but not contagious. A C. tetani infection does not result in tetanus immunity, and tetanus vaccination should be given as soon as the patient has stabilized.[2]
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Join the WikiAnswers Q&A community. Post a question or answer questions about "Clostridium tetani" at WikiAnswers.
Copyrights:
 |
 | Sci-Tech Dictionary. McGraw-Hill Dictionary of Scientific and Technical Terms. Copyright © 2003, 1994, 1989, 1984, 1978, 1976, 1974 by McGraw-Hill Companies, Inc. All rights reserved. Read more |
 |
| Dental Dictionary. Mosby's Dental Dictionary. Copyright © 2004 by Elsevier, Inc. All rights reserved. Read more |
 |
| Medical Dictionary. The American Heritage® Stedman's Medical Dictionary Copyright © 2002, 2001, 1995 by Houghton Mifflin Company. Read more |
 |
| Wikipedia. This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Clostridium tetani". Read more |
Search for answers directly from your browser with the FREE Answers.com Toolbar!
Click here to download now. 
Get Answers your way! Check out all our free tools and products.
Mentioned In:
